|
Market Cap (19-May) $4,758,880 (1,313th) |
Close (30-Jun) $1.51 |
Volume (30-Jun) 12,937 |
Shortsold (8-Aug) 2,108 (0.02%) (508th) |
|
52w High $1.09 |
52w Low $0.280 |
P/E - |
EPS -0.42 |
ZLD released this announcement to the ASX on 16 October 2020, 17:04. The announcement is not marked as price sensitive, and is 16 page(s) in length and 472.42kb in size.
You can view all announcements from ZLD and see how they appear on a price chart on the announcements page.
At the date of this announcement, ZLD was 0.010% short sold according to ASIC data. It was ranked the 510th most shorted stock on the ASX. It is now ranked as the 508th most shorted stock on the ASX with 0.019% of total shares short sold as of the latest reported data (08 August 2024).
| Other Recent Announcements from ZLD | |
|---|---|
| Amendment to ASX announcement - Zelira's diabetic nerve pai | 8 June 2023, 9:47 |
| Initial Director's Interest Notice | 1 June 2023, 15:29 |
| Final Director's Interest Notice | 1 June 2023, 15:27 |
| Proposed issue of securities - ZLD | 31 May 2023, 16:22 |
| Zelira Non-Executive Director Appointed | 31 May 2023, 16:14 |
| Top Line Results Investor Presentation | 31 May 2023, 11:46 |
| Cleansing Notice and Appendix 2A | 16 October 2020, 17:04 |
| There has been no announcements made to the ASX since this one. |
You must be logged in to post a reply.
Zelira Therapeutics 